Pershing Edward filed Form 4 on 2026-10-13.
- Filed by Pershing Edward
- Date: 2026-10-13
- Converted 8% note into 22,609 Series D-1 Preferred Stock
Edward Pershing, reporting
PVCT
PROVECTUS BIOPHARMACEUTICALS, INC. SEC filings
Every EDGAR filing for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), newest first, with AI summaries and stories.
- Ticker
- PVCT
- CIK
- 315545
- Latest filing
- 6d
Next: 10-Q expected ~Nov 13 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE PVCT CEO converts note into preferred stock
- 10/03/2026: 2025 Note converted into 13,216 Series D-1 Preferred Stock
- Series D-1 Preferred Stock converts to 10 shares of common stock
- Value of preferred stock: $705,000
Edward Pershing
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
NOTABLE10-QPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE NOTABLESCHEDULE 13D/APROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Ownership stake disclosure by Edward Pershing (amended)
Edward Pershing, filed by
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE 3 insider filings
Dominic Rodrigues, insider filing for PVCT
Show all 3
- 4Insider filing for PVCT
- 4Insider filing for PVCT
- 4Insider filing for PVCT
Dominic Rodrigues, reporting
ROUTINE8-KPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE8-KPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
NOTABLE10-QPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINEARSPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINEDEFA14APROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINEDEF 14APROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE8-KPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINEPRE 14APROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE 2 insider filings
Edward Pershing, insider filing for PVCT
Show all 2
- 4Insider filing for PVCT
- 4Insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE8-KPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
NOTABLESCHEDULE 13DPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Ownership stake disclosure by Dominic Rodrigues
Dominic Rodrigues, filed by
NOTABLESCHEDULE 13D/APROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Ownership stake disclosure by Edward Pershing (amended)
Edward Pershing, filed by
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE PROVECTUS BIOPHARMACEUTICALS, INC. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Edward Pershing, reporting
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting
NOTABLE10-QPROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Provectus Biopharmaceuticals, Inc. (PVCT) has filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational activities.
ROUTINE4PROVECTUS BIOPHARMACEUTICALS, INC.PVCTLIVE Edward Pershing, insider filing for PVCT
Edward Pershing, reporting